Takeda to buy Ariad Pharmaceuticals for $5.2bn

By PBR Staff Writer

Japan's Takeda Pharmaceutical has agreed to acquire US cancer drug maker Ariad Pharmaceuticals in a transaction worth about $5.2bn.